A 0 1 0 1 O
negative 2 10 2 10 O
serum 11 16 11 16 O
or 17 19 17 19 O
pregnancy 20 29 20 29 B-pregnancy
test 30 34 30 34 O
is 35 37 35 37 O
required 38 46 38 46 O
no 47 49 47 49 O
more 50 54 50 54 O
than 55 59 55 59 O
7 60 61 60 61 B-lower_bound
days 62 66 62 66 I-lower_bound
before 67 73 67 73 I-lower_bound
study 74 79 74 79 O
entry 80 85 80 85 O

AST 0 3 86 89 B-clinical_variable
/ 3 4 89 90 O
ALT 4 7 90 93 B-clinical_variable
≤2.5 8 12 94 98 O
X 13 14 99 100 I-upper_bound
institutional 15 28 101 114 I-upper_bound
upper 29 34 115 120 I-upper_bound
limit 35 40 121 126 I-upper_bound
of 41 43 127 129 I-upper_bound
normal 44 50 130 136 I-upper_bound

Acute 0 5 137 142 O
or 6 8 143 145 O
chronic 9 16 146 153 O
, 16 17 153 154 O
clinically 18 28 155 165 O
significant 29 40 166 177 O
hematologic 41 52 178 189 O
, 52 53 189 190 O
pulmonary 54 63 191 200 O
, 63 64 200 201 O
cardiovascular 65 79 202 216 O
, 79 80 216 217 O
or 81 83 218 220 O
hepatic 84 91 221 228 O
or 92 94 229 231 O
renal 95 100 232 237 O
functional 101 111 238 248 O
abnormality 112 123 249 260 O
as 124 126 261 263 O
determined 127 137 264 274 O
by 138 140 275 277 O
the 141 144 278 281 O
investigator 145 157 282 294 O
based 158 163 295 300 O
on 164 166 301 303 O
medical 167 174 304 311 O
history 175 182 312 319 O
, 182 183 319 320 O
physical 184 192 321 329 O
examination 193 204 330 341 O
, 204 205 341 342 O
EKG 206 209 343 346 B-treatment
, 209 210 346 347 O
and/or 211 217 348 354 O
laboratory 218 228 355 365 B-treatment
screening 229 238 366 375 I-treatment
test 239 243 376 380 I-treatment

Adequate 0 8 381 389 O
organ 9 14 390 395 O
and 15 18 396 399 O
marrow 19 25 400 406 O
function 26 34 407 415 O
no 35 37 416 418 O
more 38 42 419 423 O
than 43 47 424 428 O
28 48 50 429 431 B-upper_bound
days 51 55 432 436 I-upper_bound
prior 56 61 437 442 I-upper_bound
to 62 64 443 445 O
the 65 68 446 449 O
start 69 74 450 455 O
of 75 77 456 458 O
neoadjuvant 78 89 459 470 O
endocrine 90 99 471 480 B-treatment
therapy 100 107 481 488 I-treatment
or 108 110 489 491 O
chemotherapy 111 123 492 504 B-treatment

Any 0 3 505 508 O
chronic 4 11 509 516 O
or 12 14 517 519 O
active 15 21 520 526 O
neurologic 22 32 527 537 B-chronic_disease
disorder 33 41 538 546 I-chronic_disease
, 41 42 546 547 O
including 43 52 548 557 O
seizures 53 61 558 566 B-chronic_disease
and 62 65 567 570 O
epilepsy 66 74 571 579 B-chronic_disease

At 0 2 580 582 O
least 3 8 583 588 O
1 9 10 589 590 B-lower_bound
measurable 11 21 591 601 O
lesion 22 28 602 608 O

At 0 2 609 611 O
least 3 8 612 617 O
18 9 11 618 620 B-lower_bound
years 12 17 621 626 I-lower_bound
of 18 20 627 629 O
age 21 24 630 633 B-age

Biotherapy 0 10 634 644 B-treatment

Candidate 0 9 645 654 O
for 10 13 655 658 O
neoadjuvant 14 25 659 670 B-treatment
endocrine 26 35 671 680 I-treatment
therapy 36 43 681 688 I-treatment
or 44 46 689 691 O
chemotherapy 47 59 692 704 B-treatment

Chemotherapy 0 12 705 717 B-treatment

Clinical 0 8 718 726 O
T2 9 11 727 729 O
- 11 12 729 730 O
T4c 12 15 730 733 O
, 15 16 733 734 O
any 17 20 735 738 O
N 21 22 739 740 O
, 22 23 740 741 O
M0 24 26 742 744 O
invasive 27 35 745 753 O
ER+ 36 39 754 757 O
( 40 41 758 759 O
Allred 41 47 759 765 B-clinical_variable
Score 48 53 766 771 I-clinical_variable
of 54 56 772 774 O
6 57 58 775 776 B-lower_bound
- 58 59 776 777 O
8) 59 61 777 779 B-upper_bound
and 62 65 780 783 O
HER2- 66 71 784 789 O
( 72 73 790 791 O
0 73 74 791 792 O
or 75 77 793 795 O
1 78 79 796 797 O
+ 79 80 797 798 O
by 81 83 799 801 O
IHC 84 87 802 805 O
or 88 90 806 808 O
FISH 91 95 809 813 O
negative 96 104 814 822 O
for 105 108 823 826 O
amplification 109 122 827 840 O
) 122 123 840 841 O
breast 124 130 842 848 B-cancer
cancer 131 137 849 855 I-cancer
by 138 140 856 858 O
AJCC 141 145 859 863 O
7th 146 149 864 867 O
edition 150 157 868 875 O
clinical 158 166 876 884 O
staging 167 174 885 892 O
, 174 175 892 893 O
with 176 180 894 898 O
the 181 184 899 902 O
goal 185 189 903 907 O
being 190 195 908 913 O
surgery 196 203 914 921 B-treatment
to 204 206 922 924 O
completely 207 217 925 935 O
excise 218 224 936 942 O
the 225 228 943 946 O
tumor 229 234 947 952 B-cancer
in 235 237 953 955 O
the 238 241 956 959 O
breast 242 248 960 966 O
and 249 252 967 970 O
the 253 256 971 974 O
lymph 257 262 975 980 O
node 263 267 981 985 O

Clinical 0 8 986 994 O
assessment 9 19 995 1005 O
by 20 22 1006 1008 O
treating 23 31 1009 1017 O
physician 32 41 1018 1027 O
that 42 46 1028 1032 O
the 47 50 1033 1036 O
patient 51 58 1037 1044 O
is 59 61 1045 1047 O
responding 62 72 1048 1058 O
to 73 75 1059 1061 O
neoadjuvant 76 87 1062 1073 B-treatment
therapy 88 95 1074 1081 I-treatment
or 96 98 1082 1084 O
umor 99 103 1085 1089 B-clinical_variable
Ki67 104 108 1090 1094 I-clinical_variable
value 109 114 1095 1100 I-clinical_variable
is 115 117 1101 1103 O
≤ 118 119 1104 1105 O
10 120 122 1106 1108 B-upper_bound
% 122 123 1108 1109 I-upper_bound
after 124 129 1110 1115 B-upper_bound
14 130 132 1116 1118 I-upper_bound
days 133 137 1119 1123 I-upper_bound

Confirmation 0 12 1124 1136 O
that 13 17 1137 1141 O
primary 18 25 1142 1149 B-cancer
tumor 26 31 1150 1155 I-cancer
expresses 32 41 1156 1165 O
mammaglobin 42 53 1166 1177 B-clinical_variable
- 53 54 1177 1178 I-clinical_variable
A 54 55 1178 1179 I-clinical_variable
by 56 58 1180 1182 O
IHC 59 62 1183 1186 B-treatment

Current 0 7 1187 1194 O
use 8 11 1195 1198 O
of 12 14 1199 1201 O
any 15 18 1202 1205 O
electronic 19 29 1206 1216 B-treatment
stimulation 30 41 1217 1228 I-treatment
device 42 48 1229 1235 I-treatment
, 48 49 1235 1236 O
such 50 54 1237 1241 O
as 55 57 1242 1244 O
cardiac 58 65 1245 1252 O
demand 66 72 1253 1259 O
pacemakers 73 83 1260 1270 B-treatment
, 83 84 1270 1271 O
automatic 85 94 1272 1281 O
implantable 95 106 1282 1293 B-treatment
cardiac 107 114 1294 1301 I-treatment
defibrillator 115 128 1302 1315 I-treatment
, 128 129 1315 1316 O
nerve 130 135 1317 1322 B-treatment
stimulators 136 147 1323 1334 I-treatment
, 147 148 1334 1335 O
or 149 151 1336 1338 O
deep 152 156 1339 1343 B-treatment
brain 157 162 1344 1349 I-treatment
stimulators 163 174 1350 1361 I-treatment

Eastern 0 7 1362 1369 B-clinical_variable
Cooperative 8 19 1370 1381 I-clinical_variable
Oncology 20 28 1382 1390 I-clinical_variable
Group 29 34 1391 1396 I-clinical_variable
( 35 36 1397 1398 I-clinical_variable
ECOG 36 40 1398 1402 I-clinical_variable
) 40 41 1402 1403 I-clinical_variable
performance 42 53 1404 1415 I-clinical_variable
status 54 60 1416 1422 I-clinical_variable
≤2 61 63 1423 1425 O

FSH 0 3 1426 1429 B-clinical_variable
and 4 7 1430 1433 O
estradiol 8 17 1434 1443 B-clinical_variable
levels 18 24 1444 1450 I-clinical_variable
in 25 27 1451 1453 O
premenopausal 28 41 1454 1467 O
range 42 47 1468 1473 O
, 47 48 1473 1474 O
according 49 58 1475 1484 O
to 59 61 1485 1487 O
institutional 62 75 1488 1501 O
standards 76 85 1502 1511 O

Hormonal 0 8 1512 1520 B-treatment
therapy 9 16 1521 1528 I-treatment

Individuals 0 11 1529 1540 O
in 12 14 1541 1543 O
whom 15 19 1544 1548 O
a 20 21 1549 1550 O
skinfold 22 30 1551 1559 B-clinical_variable
measurement 31 42 1560 1571 I-clinical_variable
of 43 45 1572 1574 I-clinical_variable
the 46 49 1575 1578 I-clinical_variable
cutaneous 50 59 1579 1588 I-clinical_variable
and 60 63 1589 1592 I-clinical_variable
subcutaneous 64 76 1593 1605 I-clinical_variable
tissue 77 83 1606 1612 I-clinical_variable
for 84 87 1613 1616 I-clinical_variable
the 88 91 1617 1620 I-clinical_variable
eligible 92 100 1621 1629 I-clinical_variable
injection 101 110 1630 1639 I-clinical_variable
sites 111 116 1640 1645 I-clinical_variable
( 117 118 1646 1647 I-clinical_variable
left 118 122 1647 1651 I-clinical_variable
and 123 126 1652 1655 I-clinical_variable
right 127 132 1656 1661 I-clinical_variable
medial 133 139 1662 1668 I-clinical_variable
deltoid 140 147 1669 1676 I-clinical_variable
region 148 154 1677 1683 I-clinical_variable
) 154 155 1683 1684 I-clinical_variable
exceeds 156 163 1685 1692 O
40 164 166 1693 1695 B-lower_bound
mm 167 169 1696 1698 I-lower_bound

Investigational 0 15 1699 1714 B-treatment
agent 16 21 1715 1720 I-treatment

Known 0 5 1721 1726 O
HIV 6 9 1727 1730 B-chronic_disease
- 9 10 1730 1731 O
positive 10 18 1731 1739 O
status 19 25 1740 1746 O

Known 0 5 1747 1752 O
allergy 6 13 1753 1760 O
, 13 14 1760 1761 O
or 15 17 1762 1764 O
history 18 25 1765 1772 O
of 26 28 1773 1775 O
serious 29 36 1776 1783 O
adverse 37 44 1784 1791 O
reaction 45 53 1792 1800 O
to 54 56 1801 1803 O
vaccines 57 65 1804 1812 B-treatment
such 66 70 1813 1817 O
as 71 73 1818 1820 O
anaphylaxis 74 85 1821 1832 B-allergy_name
, 85 86 1832 1833 O
hives 87 92 1834 1839 B-allergy_name
, 92 93 1839 1840 O
or 94 96 1841 1843 O
respiratory 97 108 1844 1855 B-allergy_name
difficulty 109 119 1856 1866 I-allergy_name

Known 0 5 1867 1872 O
metastatic 6 16 1873 1883 B-chronic_disease
disease 17 24 1884 1891 I-chronic_disease

Newly 0 5 1892 1897 O
diagnosed 6 15 1898 1907 O
histologically 16 30 1908 1922 O
confirmed 31 40 1923 1932 O
invasive 41 49 1933 1941 O
breast 50 56 1942 1948 B-cancer
cancer 57 63 1949 1955 I-cancer

Postmenopausal 0 14 1956 1970 O
women 15 20 1971 1976 B-gender

Pregnant 0 8 1977 1985 B-pregnancy

Premenopausal 0 13 1986 1999 O
women 14 19 2000 2005 B-gender

Prior 0 5 2006 2011 O
axillary 6 14 2012 2020 O
lymph 15 20 2021 2026 O
node 21 25 2027 2031 O
sampling 26 34 2032 2040 O
( 35 36 2041 2042 O
sentinel 36 44 2042 2050 B-treatment
lymph 45 50 2051 2056 I-treatment
node 51 55 2057 2061 I-treatment
biopsy 56 62 2062 2068 I-treatment
or 63 65 2069 2071 O
axillary 66 74 2072 2080 B-treatment
lymph 75 80 2081 2086 I-treatment
node 81 85 2087 2091 I-treatment
dissection 86 96 2092 2102 I-treatment
) 96 97 2102 2103 O

Prior 0 5 2104 2109 O
or 6 8 2110 2112 O
currently 9 18 2113 2122 O
active 19 25 2123 2129 O
autoimmune 26 36 2130 2140 B-chronic_disease
disease 37 44 2141 2148 I-chronic_disease
requiring 45 54 2149 2158 O
management 55 65 2159 2169 O
with 66 70 2170 2174 O
immunosuppression 71 88 2175 2192 B-treatment

Radiation 0 9 2193 2202 B-treatment
therapy 10 17 2203 2210 I-treatment

Receiving 0 9 2211 2220 O
any 10 13 2221 2224 O
other 14 19 2225 2230 O
investigational 20 35 2231 2246 B-treatment
agent(s 36 43 2247 2254 I-treatment
) 43 44 2254 2255 I-treatment
or 45 47 2256 2258 O
has 48 51 2259 2262 O
received 52 60 2263 2271 O
an 61 63 2272 2274 O
investigational 64 79 2275 2290 O
agent 80 85 2291 2296 O
within 86 92 2297 2303 O
the 93 96 2304 2307 O
last 97 101 2308 2312 B-upper_bound
30 102 104 2313 2315 I-upper_bound
days 105 109 2316 2320 I-upper_bound

Surgery 0 7 2321 2328 B-treatment

Syncopal 0 8 2329 2337 B-chronic_disease
episode 9 16 2338 2345 I-chronic_disease
within 17 23 2346 2352 O
12 24 26 2353 2355 B-upper_bound
months 27 33 2356 2362 I-upper_bound
of 34 36 2363 2365 O
screening 37 46 2366 2375 O

Therapeutic 0 11 2376 2387 B-treatment
or 12 14 2388 2390 O
traumatic 15 24 2391 2400 B-treatment
metal 25 30 2401 2406 I-treatment
implant 31 38 2407 2414 I-treatment
in 39 41 2415 2417 O
the 42 45 2418 2421 O
skin 46 50 2422 2426 O
or 51 53 2427 2429 O
muscle 54 60 2430 2436 O
of 61 63 2437 2439 O
either 64 70 2440 2446 O
deltoid 71 78 2447 2454 O
region 79 85 2455 2461 O

This 0 4 2462 2466 O
includes 5 13 2467 2475 O
inflammatory 14 26 2476 2488 B-chronic_disease
bowel 27 32 2489 2494 I-chronic_disease
disease 33 40 2495 2502 I-chronic_disease
, 40 41 2502 2503 O
ulcerative 42 52 2504 2514 B-chronic_disease
colitis 53 60 2515 2522 I-chronic_disease
, 60 61 2522 2523 O
Crohn 62 67 2524 2529 B-chronic_disease
's 67 69 2529 2531 I-chronic_disease
disease 70 77 2532 2539 I-chronic_disease
, 77 78 2539 2540 O
systemic 79 87 2541 2549 O
vasculitis 88 98 2550 2560 B-chronic_disease
, 98 99 2560 2561 O
scleroderma 100 111 2562 2573 B-chronic_disease
, 111 112 2573 2574 O
psoriasis 113 122 2575 2584 B-chronic_disease
, 122 123 2584 2585 O
multiple 124 132 2586 2594 B-chronic_disease
sclerosis 133 142 2595 2604 I-chronic_disease
, 142 143 2604 2605 O
hemolytic 144 153 2606 2615 B-chronic_disease
anemia 154 160 2616 2622 I-chronic_disease
, 160 161 2622 2623 O
immune 162 168 2624 2630 B-chronic_disease
- 168 169 2630 2631 I-chronic_disease
mediated 169 177 2631 2639 I-chronic_disease
thrombocytopenia 178 194 2640 2656 I-chronic_disease
, 194 195 2656 2657 O
rheumatoid 196 206 2658 2668 B-chronic_disease
arthritis 207 216 2669 2678 I-chronic_disease
, 216 217 2678 2679 O
systemic 218 226 2680 2688 B-chronic_disease
lupus 227 232 2689 2694 I-chronic_disease
erythematosus 233 246 2695 2708 I-chronic_disease
, 246 247 2708 2709 O
Sjogren 248 255 2710 2717 B-chronic_disease
's 255 257 2717 2719 I-chronic_disease
syndrome 258 266 2720 2728 I-chronic_disease
, 266 267 2728 2729 O
sarcoidosis 268 279 2730 2741 B-chronic_disease
, 279 280 2741 2742 O
or 281 283 2743 2745 O
other 284 289 2746 2751 O
rheumatologic 290 303 2752 2765 B-chronic_disease
disease 304 311 2766 2773 I-chronic_disease
or 312 314 2774 2776 O
any 315 318 2777 2780 O
other 319 324 2781 2786 O
medical 325 332 2787 2794 O
condition 333 342 2795 2804 O
or 343 345 2805 2807 O
use 346 349 2808 2811 O
of 350 352 2812 2814 O
medication 353 363 2815 2825 B-treatment
( 364 365 2826 2827 O
e.g. 365 369 2827 2831 O
, 369 370 2831 2832 O
corticosteroids 371 386 2833 2848 B-treatment
) 386 387 2848 2849 O
which 388 393 2850 2855 O
might 394 399 2856 2861 O
make 400 404 2862 2866 O
it 405 407 2867 2869 O
difficult 408 417 2870 2879 O
for 418 421 2880 2883 O
the 422 425 2884 2887 O
patient 426 433 2888 2895 O
to 434 436 2896 2898 O
complete 437 445 2899 2907 O
the 446 449 2908 2911 O
full 450 454 2912 2916 O
course 455 461 2917 2923 O
of 462 464 2924 2926 O
treatments 465 475 2927 2937 B-treatment
or 476 478 2938 2940 O
to 479 481 2941 2943 O
generate 482 490 2944 2952 O
an 491 493 2953 2955 O
immune 494 500 2956 2962 O
response 501 509 2963 2971 O
to 510 512 2972 2974 O
vaccines 513 521 2975 2983 O

Uncontrolled 0 12 2984 2996 O
intercurrent 13 25 2997 3009 B-chronic_disease
illness 26 33 3010 3017 I-chronic_disease
including 34 43 3018 3027 O
, 43 44 3027 3028 O
but 45 48 3029 3032 O
not 49 52 3033 3036 O
limited 53 60 3037 3044 O
to 61 63 3045 3047 O
ongoing 64 71 3048 3055 O
or 72 74 3056 3058 O
active 75 81 3059 3065 B-chronic_disease
infection 82 91 3066 3075 I-chronic_disease
, 91 92 3075 3076 O
symptomatic 93 104 3077 3088 O
congestive 105 115 3089 3099 B-chronic_disease
heart 116 121 3100 3105 I-chronic_disease
failure 122 129 3106 3113 I-chronic_disease
, 129 130 3113 3114 O
unstable 131 139 3115 3123 B-chronic_disease
angina 140 146 3124 3130 I-chronic_disease
pectoris 147 155 3131 3139 I-chronic_disease
, 155 156 3139 3140 O
cardiac 157 164 3141 3148 B-chronic_disease
arrhythmia 165 175 3149 3159 I-chronic_disease
, 175 176 3159 3160 O
or 177 179 3161 3163 O
psychiatric 180 191 3164 3175 B-chronic_disease
illness 192 199 3176 3183 I-chronic_disease
/ 199 200 3183 3184 O
social 200 206 3184 3190 B-chronic_disease
situation 207 216 3191 3200 I-chronic_disease
that 217 221 3201 3205 O
would 222 227 3206 3211 O
limit 228 233 3212 3217 O
compliance 234 244 3218 3228 O
with 245 249 3229 3233 O
study 250 255 3234 3239 O
requirements 256 268 3240 3252 O

WBC 0 3 3253 3256 B-clinical_variable
≥3,000 4 10 3257 3263 O
/ 10 11 3263 3264 I-lower_bound
μL 11 13 3264 3266 I-lower_bound

Women 0 5 3267 3272 B-gender
of 6 8 3273 3275 O
childbearing 9 21 3276 3288 O
potential 22 31 3289 3298 O
must 32 36 3299 3303 O
use 37 40 3304 3307 B-contraception_consent
two 41 44 3308 3311 I-contraception_consent
forms 45 50 3312 3317 I-contraception_consent
of 51 53 3318 3320 I-contraception_consent
contraception 54 67 3321 3334 I-contraception_consent
( 68 69 3335 3336 O
hormonal 69 77 3336 3344 B-contraception_consent
or 78 80 3345 3347 O
barrier 81 88 3348 3355 B-contraception_consent
method 89 95 3356 3362 I-contraception_consent
of 96 98 3363 3365 I-contraception_consent
birth 99 104 3366 3371 I-contraception_consent
control 105 112 3372 3379 I-contraception_consent
; 112 113 3379 3380 O
abstinence 114 124 3381 3391 B-contraception_consent
) 124 125 3391 3392 O
prior 126 131 3393 3398 O
to 132 134 3399 3401 O
study 135 140 3402 3407 O
entry 141 146 3408 3413 O
and 147 150 3414 3417 O
for 151 154 3418 3421 O
the 155 158 3422 3425 O
duration 159 167 3426 3434 O
of 168 170 3435 3437 O
study 171 176 3438 3443 O
participation 177 190 3444 3457 O

absolute 0 8 3458 3466 B-clinical_variable
neutrophil 9 19 3467 3477 I-clinical_variable
count 20 25 3478 3483 I-clinical_variable
≥1,500 26 32 3484 3490 O
/ 32 33 3490 3491 I-lower_bound
μL 33 35 3491 3493 I-lower_bound

bilateral 0 9 3494 3503 O
surgical 10 18 3504 3512 B-treatment
oophorectomy 19 31 3513 3525 I-treatment

creatinine 0 10 3526 3536 B-clinical_variable
≤ 11 12 3537 3538 O
institutional 13 26 3539 3552 B-clinical_variable
upper 27 32 3553 3558 I-clinical_variable
limit 33 38 3559 3564 I-clinical_variable
of 39 41 3565 3567 I-clinical_variable
normal 42 48 3568 3574 I-clinical_variable
OR 49 51 3575 3577 O
creatinine 52 62 3578 3588 B-clinical_variable
clearance 63 72 3589 3598 I-clinical_variable
≥ 73 74 3599 3600 O
60 75 77 3601 3603 B-lower_bound
mL 78 80 3604 3606 I-lower_bound
/ 80 81 3606 3607 I-lower_bound
min/1.73 81 89 3607 3615 I-lower_bound
m2 90 92 3616 3618 I-lower_bound
for 93 96 3619 3622 O
patients 97 105 3623 3631 O
with 106 110 3632 3636 O
creatinine 111 121 3637 3647 O
above 122 127 3648 3653 O
IULN 128 132 3654 3658 B-clinical_variable

no 0 2 3659 3661 O
menses 3 9 3662 3668 O
for 10 13 3669 3672 O
< 14 15 3673 3674 O
1 15 16 3674 3675 B-upper_bound
year 17 21 3676 3680 I-upper_bound
with 22 26 3681 3685 O
FSH 27 30 3686 3689 B-treatment
and 31 34 3690 3693 O
estradiol 35 44 3694 3703 B-clinical_variable
levels 45 51 3704 3710 I-clinical_variable
in 52 54 3711 3713 O
postmenopausal 55 69 3714 3728 O
range 70 75 3729 3734 O
, 75 76 3734 3735 O
according 77 86 3736 3745 O
to 87 89 3746 3748 O
institutional 90 103 3749 3762 O
standards 104 113 3763 3772 O

no 0 2 3773 3775 O
spontaneous 3 14 3776 3787 O
menses 15 21 3788 3794 B-clinical_variable
≥ 22 23 3795 3796 O
1 24 25 3797 3798 B-lower_bound
year 26 30 3799 3803 I-lower_bound

patients 0 8 3804 3812 O
must 9 13 3813 3817 O
be 14 16 3818 3820 O
willing 17 24 3821 3828 B-contraception_consent
to 25 27 3829 3831 I-contraception_consent
employ 28 34 3832 3838 I-contraception_consent
adequate 35 43 3839 3847 I-contraception_consent
contraception 44 57 3848 3861 I-contraception_consent

platelets 0 9 3862 3871 B-clinical_variable
≥100,000 10 18 3872 3880 O
/ 18 19 3880 3881 I-lower_bound
μL 19 21 3881 3883 I-lower_bound

total 0 5 3884 3889 B-clinical_variable
bilirubin 6 15 3890 3899 I-clinical_variable
≤institutional 16 30 3900 3914 O
upper 31 36 3915 3920 O
limit 37 42 3921 3926 O
of 43 45 3927 3929 O
normal 46 52 3930 3936 O

